Mesenchymal stem cell-based therapy for type 1 diabetes.
Year: 2014
Type: article
Source: PubMed
Authors: Hao Wu, Ram I Mahato
Institution: NGM Biopharmaceuticals (United States)
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W180375144
